[BRASH症候群: ブラディカルディア,高カリミア,腎不全の悪循環]

Tamar J A Kooger^1,2, Linda de Nooij¹, Ernesto Gilly Simon³

¹Noordwest Ziekenhuis, Alkmaar. Afd. Spoedeisende Hulp.

Nederlands tijdschrift voor geneeskunde

|September 4, 2025

まとめ

BRASH症候群は,ブラディカルディア,腎不全, AV阻害,ショック,および高カリミアの危険な相互作用であり,迅速な認識が必要です. 早期の介入によりリスクの高い患者の多臓器不全を防ぐことができます

科学分野:

心臓病科
腎臓科
臨床医学

背景:

BRASH症候群は,AVノードル阻害薬,腎不全,高カリミアの相互作用によって生じる複雑な臨床実体です.
この相乗効果はブラディカルディアと腎臓の低血流を引き起こし,有害な循環を生み出します.
この状態は,多臓器不全の重大なリスクをもたらし,特に心血管疾患や腎臓疾患を患っている患者には特に危険です.

研究の目的:

BRASH症候群の早期発見が極めて重要であることを強調します
このしばしば見過ごされる病気の診断上の課題と管理戦略を強調する
心血管疾患と腎臓疾患を併合した患者の注意の必要性を強調する.

主な方法:

ケースレポートのプレゼンテーション
BRASH症候群とその要因に関する既存の文献のレビュー
臨床表現,診断結果,治療介入の分析

主要な成果:

この症例は,AVノードル阻害,腎機能障害,高カロリー症の相互作用によるBRASH症候群の急速な進行を示しています.
治療の成功には,AVノードルブロッカーの迅速な中止,高カリミアの矯正,および補足的な補水が必要でした.
早期の診断と介入は患者の好転に不可欠です

結論:

BRASH症候群は,心血管および腎臓障害の患者で高い疑い指数を必要とする重大な状態を表します.
BRASH症候群の治療には基本的なサポート療法が有効です
重篤な合併症を予防し患者の生存率を向上させるには意識の向上と早期発見が不可欠です

さらに関連する動画

12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K

08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

17.9K

関連する概念動画

01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

118

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...

118

01:14

Decreased pulse rate

618

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...

618

01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

746

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...

746

01:29

Disturbances in Heart Rhythm

1.2K

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

1.2K

01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

505

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

505

01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

関連する実験動画